http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104198735-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104198735-B |
| titleOfInvention | Use MR proADM diabetes diagnosis and risk stratification |
| abstract | The present invention relates to the diabetes diagnosis and risk stratification using MR proADM.Specifically, the present invention relates to diabetes, the particularly diagnosis of diabetes with secondary disease and/or method for risk stratification, wherein carrying out mark central area adrenomedulin original (MR proADM in patient to be studied:SEQ ID No.2) or part thereof peptide or fragment measure, or be measured if it is included in mark combination (mark group, mark cluster).In addition, the present invention relates to the diagnostic device and kit for carrying out methods described. |
| priorityDate | 2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 451.